(81 days)
The Access & Support Catheter is intended for use during coronary and peripheral interventional procedures to guide and support guidewires, traverse discrete portions of the vasculature, allow for guidewire exchanges and provide a conduit for infusion of saline solution, diagnostic contrast agents and therapeutic agents.
The Access & Support Catheter is an over-the-wire (OTW) single-lumen catheter with an atraumatic tapered tip. The catheter is offered in twelve (12) size models as outlined in the following table. The catheter shaft consists of high density polyethylene (HDPE) with distal platinum/iridium markerbands. The distal 40 cm outer portion of all catheters have a hydrophilic coating. The proximal portion includes a PEBA strain relief with a HDPE manifold which incorporates a female luer connection which communicates with the catheter lumen. The catheter through lumen is used to pass the catheter over the appropriate guidewire or for infusion. When used for infusion, the maximum infusion pressure should not exceed 300 psi. The catheter guidewire compatibility size and length are printed on the strain relief. All models are compatible with 5 Fr introducer sheaths and 6 Fr guiding catheters. All devices are provided sterile and intended for single use only.
The provided text is a 510(k) Summary for a medical device called the "Access & Support Catheter." It outlines the device's design, intended use, and a comparison to predicate devices, primarily focusing on non-clinical performance data. It explicitly states that "All tests demonstrated the materials, manufacturing processes, and design of the Access & Support Catheter met the established performance criteria and will perform as intended." However, the document does not contain information about a study proving the device meets acceptance criteria in the context of clinical performance or algorithm-based diagnostics.
Instead, it describes the results of non-clinical bench testing and biocompatibility tests to demonstrate substantial equivalence to predicate devices, focusing on physical properties and material safety.
Therefore, many of the requested categories for a study proving acceptance criteria (especially those related to human readers, ground truth establishment for a test set, and multi-reader multi-case studies) are not applicable to the information provided.
Here's a summary based on the provided text, highlighting the absence of information for certain criteria:
1. Table of Acceptance Criteria and Reported Device Performance
The document lists various non-clinical tests conducted and states that performance criteria were met. It does not provide specific numerical acceptance criteria or detailed quantitative performance results for each test in a table format. Instead, it offers a qualitative statement of compliance.
| Acceptance Criteria Category | Reported Device Performance |
|---|---|
| Mechanical Performance | |
| Visual inspections | Met established criteria |
| Dimensional evaluations | Met established criteria |
| Luer syringe compatibility | Met established criteria |
| Guidewire compatibility | Met established criteria |
| Sheath compatibility | Met established criteria |
| Guidewire support | Met established criteria |
| Catheter stiffness & flexibility, guidewire retraction & re-insertion | Met established criteria |
| Catheter fatigue | Met established criteria |
| Catheter kink resistance | Met established criteria |
| Markerband retention | Met established criteria |
| Leakage/burst (Pressure & Vacuum) | Met established criteria |
| Torque testing | Met established criteria |
| Tensile testing | Met established criteria |
| Corrosion testing | Met established criteria |
| Simulated Use | Met established criteria |
| Coating Adherence | Met established criteria |
| Particulate Evaluations | Met established criteria |
| Shelf life | Met established criteria |
| Package Integrity | Met established criteria |
| Biocompatibility | |
| Cytotoxicity | Met established criteria |
| Sensitization | Met established criteria |
| Irritation / Intracutaneous Reactivity | Met established criteria |
| Systemic Toxicity (Acute) | Met established criteria |
| Genotoxicity | Met established criteria |
| Hemolysis | Met established criteria |
| Immunology (Compliment Activation) | Met established criteria |
| In Vivo Thromboresistance | Met established criteria |
| Pyrogenicity (material mediated) | Met established criteria |
| Physicochemical Tests | Met established criteria |
2. Sample size used for the test set and the data provenance:
- Sample Size: Not specified for individual non-clinical tests. The text indicates that "The Access & Support Catheter has been evaluated using the following in vitro bench testing." This implies testing of device units, but the number of units tested for each criterion is not provided.
- Data Provenance: The tests are described as "in vitro bench testing" and "Biocompatibility tests," indicating laboratory-based, non-clinical data. No country of origin is mentioned for data, but the submitter is QXMédical, LLC, based in White Bear Lake, MN, USA. The data is retrospective in the sense that it was generated prior to submission for regulatory review.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Not applicable. The ground truth for this device is based on objective measurements and established standards for mechanical and biocompatibility performance, not expert consensus on medical images or clinical outcomes.
4. Adjudication method (e.g., 2+1, 3+1, none) for the test set:
- Not applicable. See explanation for point 3.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- Not applicable. This is not an AI-enabled diagnostic device, and no MRMC study was conducted or mentioned.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:
- Not applicable. This is a physical medical device, not a software algorithm.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
- The ground truth for non-clinical performance (mechanical, material, and biocompatibility) is based on established engineering specifications, material standards, and biological safety standards (e.g., ISO standards for biocompatibility). The tests objectively demonstrate that the device meets these predefined physical and biological requirements.
8. The sample size for the training set:
- Not applicable. As a physical medical device submission, there is no "training set" in the context of machine learning or AI.
9. How the ground truth for the training set was established:
- Not applicable. See explanation for point 8.
{0}------------------------------------------------
K 123311
JAN 1 4 2013
510(k) Summary
Date Prepared: October 5, 2012
510(k) Submitter QXMédical, LLC
1843 Buerkle Road White Bear Lake, MN 55110
Contact Person Fernando Di Caprio Phone: (651) 338-5774 Email: fernando.dicaprio@qxmedical.com
| General Information | |
|---|---|
| Trade Name | Access & Support Catheter |
| Common Name | Support catheter |
| Classification Info | Percutaneous catheter per 21 CFR 870.1250 (Class II); Product Code: DQY |
| Predicate Device | Minnie Support Catheter - Vascular Solutions, Inc. (K082337)Quick-Cross Support Catheter - Spectranetics, Inc. (K033678) |
Device Description
The Access & Support Catheter is an over-the-wire (OTW) single-lumen catheter with an atraumatic tapered tip. The catheter is offered in twelve (12) size models as outlined in the following table.
| Model # | GuidewireCompatibility | Shaft Outer Diameter(proximal / distal) | Working(Effective)Length | MarkerbandQuantity | MarkerbandSpacing |
|---|---|---|---|---|---|
| 9002-001 | 0.014" | 0.039"/0.0265" | 65cm | 3 | 15 mm |
| 9002-002 | 0.014" | 0.039"/0.0265" | 90cm | 3 | 15 mm |
| 9002-003 | 0.014" | 0.039"/0.0265" | 135cm | 3 | 15 mm |
| 9002-004 | 0.014" | 0.039"/0.0265" | 150cm | 3 | 15 mm |
| 9002-005 | 0.018" | 0.044"/0.0305" | 65cm | 3 | 15 mm |
| 9002-006 | 0.018" | 0.044"/0.0305" | 90cm | 3 | 15 mm |
| 9002-007 | 0.018" | 0.044"/0.0305" | 135cm | 3 | 15 mm |
| 9002-008 | 0.018" | 0.044"/0.0305" | 150cm | 3 | 15 mm |
| 9002-009 | 0.035" | 0.063"/0.0505" | 65cm | 3 | 50 mm |
| 9002-010 | 0.035" | 0.063"/0.0505" | 90cm | 3 | 50 mm |
| 9002-011 | 0.035" | 0.063"/0.0505" | 135cm | 3 | 50 mm |
| 9002-012 | 0.035" | 0.063"/0.0505" | 150cm | 3 | 50 mm |
The catheter shaft consists of high density polyethylene (HDPE) with distal platinum/iridium markerbands. The distal 40 cm outer portion of all catheters have a hydrophilic coating. The proximal portion includes a PEBA strain relief with a HDPE manifold which incorporates a female luer connection which communicates with the catheter lumen. The catheter through lumen is used to pass the catheter over the appropriate guidewire or for infusion. When used for
{1}------------------------------------------------
infusion, the maximum infusion pressure should not exceed 300 psi. The catheter guidewire compatibility size and length are printed on the strain relief. All models are compatible with 5 Fr introducer sheaths and 6 Fr guiding catheters. All devices are provided sterile and intended for single use only.
Intended Use / Indications
The Access & Support Catheter is intended for use during coronary and peripheral interventional procedures to guide and support guidewires, traverse discrete portions of the vasculature, allow for guidewire exchanges and provide a conduit for infusion of saline solution, diagnostic contrast agents and therapeutic agents.
Comparison to Predicates
The indication for use of the Access & Support Catheter is comparable to the predicate devices with the differences being mainly semantics. Both devices are intended to support access to the vasculature, allow for guidewire exchanges, and provide a conduit for fluid deliveries. The Access & Support Catheter uses the terms "discreet portions of the vasculature" as a more descriptive term compared to the Quick-Cross general "access of the vasculature." For comparison, the Minnie Support Catheter also uses the "discreet regions" terms as further description of the type of vasculature the catheter can be used within.
The Access & Support Catheter is technologically similar to the predicate devices in that they all are single lumen catheters utilized to exchange guidewires and/or infuse intravascular procedural agents as necessary. The Minnie Catheter is constructed of similar materials (polyethylene and hydrophilic coating) with similar working lengths ranging in size from 65cm to 150cm, and the same dimensional guidewire compatibility (0.014", and 0.035"). The Quick-Cross Support Catheter is constructed of similar materials (HDPE, Pt/Ir, and hydrophilic coating) and ranges in length from 90cm to 135cm with the same guidewire compatibilities. The following table outlines a comparison of the subject device to the predicate devices.
{2}------------------------------------------------
| Device Component /Performance Parameter | QXMédical Access &Support Catheter | Quick-Cross Catheter(K033678) | Minnie Catheter(K082337) |
|---|---|---|---|
| Manifold/Proximal Hub | HDPE | Same | PE |
| Strain Relief | PEBA | Molded from hub (HDPE) | unknown |
| Catheter Shaft | Single lumen, HDPE | Same | Single lumen, PE |
| Coating | Hydrophilic | Same | Same |
| Markers - Material (Quantity) | Pt/Ir (3) | Same | Material unknown (3) |
| Infusion Pressure | 300 psi | Same | Same |
| Outer Diameter | Varies by modelProximal:0.039", 0.044", 0.063"Distal:0.0265", 0.0305", 0.0505"Tip:0.0195", 0.0225", 0.0405" | Varies by modelProximal:0.039", 0.044", 0.063"Distal:0.0260, 0.030, 0.050"Tip:0.020, 0.023, 0.041" | Varies by modelProximal:0.039, 0.044, 0.063"Distal:0.026, 0.030, 0.050"Tip:0.020. 0.023, 0.041" |
| Effective (Working) Length | All three diameters65, 90, 135, 150 cm | Varies by model90, 135, 150 cm | Varies by model65, 90, 135, 150 cm |
| Guidewire Diameter (min.) | 0.014", 0.018", 0.035" | Same | Same |
| Guide Catheter (max.) | 5Fr | Same | 5Fr or 6Fr |
| Access Sheath (max.) | 5Fr | Same | Same |
| Single Use, Sterile | Yes | Same | Same |
| Sterilization Method | EO | Unknown | Same |
.
{3}------------------------------------------------
Summary of Non-Clinical Performance Data
The Access & Support Catheter has been evaluated using the following in vitro bench testing to confirm the performance characteristics of the device.
- Visual inspections .
- Dimensional evaluations
- Luer syringe compatibility .
- . Guidewire compatibility
- . Sheath compatibility
- . Guidewire support
- . Catheter stiffness & flexibility, guidewire retraction & re-insertion
- . Catheter fatigue
- . Catheter kink resistance
- Markerband retention
- Leakage/burst (Pressure & Vacuum)
- . Torque testing
- . Tensile testing
- . Corrosion testing
- Simulated Use .
- . Coating Adherence
- . Particulate Evaluations
- . Shelf life
- Package Integrity ●
Biocompatibility tests were completed to ensure all materials utilized to construct the Access & Support Catheter were biocompatible. Biocompatibility tests included:
- Cytotoxicity ●
- . Sensitization
- Irritation / Intracutaneous Reactivity ●
- Systemic Toxicity (Acute) ●
- . Genotoxicity
- Hemolysis .
- Immunology (Compliment Activation) .
- In Vivo Thromboresistance .
- Pyrogenicity (material mediated) ●
- Physicochemical Tests .
All tests demonstrated the materials, manufacturing processes, and design of the Access & Support Catheter met the established performance criteria and will perform as intended. The above non-clinical tests demonstrate that the device is safe and effective and performs as safely and effectively as the legally marketed predicate devices.
{4}------------------------------------------------
Substantial Equivalence Comparison Summary
Based upon the intended use and descriptive information provided in this pre-market notification, the QXMédical Access & Support Catheter has been shown to be substantially equivalent to the predicate devices. The QXMédical Access & Support Catheter raises no new questions of safety or effectiveness when compared to the predicate devices and is, therefore, substantially equivalent.
{5}------------------------------------------------
Image /page/5/Picture/0 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized symbol that resembles an abstract caduceus or a representation of human services.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
QXMedical, LLC c/o Mark Job . Regulatory Technology Services, LLC 1394 24th Street NW Buffalo, MN 55313
Re: K123311
Trade/Device Name: VELO Access and Support Catheter Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous Catheter Regulatory Class: Class II Product Code: DOY Dated: November 20, 2012 Received: November 21, 2012
Dear Mr. Job:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
JAN 1 4 2013
{6}------------------------------------------------
Page 2 - Mr. Mark Job
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Matthew G. Hillebrenner
for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{7}------------------------------------------------
Indications for Use
510(k) Number (if known): K123311
Device Name: QXMédical Access & Support Catheter
Indications for Use:
The Access & Support Catheter is intended for use during coronary and peripheral interventional procedures to guide and support guidewires, traverse discrete portions of the vasculature, allow for guidewire exchanges and provide a conduit for infusion of saline solution, diagnostic contrast agents and therapeutic agents.
Prescription Use × (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
M.A. Lillehem
§ 870.1250 Percutaneous catheter.
(a)
Identification. A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.(b)
Classification. Class II (performance standards).